美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70511-113-10	70511-113	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181227	N/A	ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	500 ug/5mL	1 VIAL, SINGLE-USE in 1 CARTON (70511-113-10) / 5 mL in 1 VIAL, SINGLE-USE
25021-468-10	25021-468	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101	N/A	ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	100 ug/5mL	1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL
25021-469-10	25021-469	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101	N/A	ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	200 ug/5mL	1 VIAL in 1 CARTON (25021-469-10) / 5 mL in 1 VIAL
70511-111-10	70511-111	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191227	N/A	ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	100 ug/5mL	1 VIAL, SINGLE-USE in 1 CARTON (70511-111-10) / 5 mL in 1 VIAL, SINGLE-USE
25021-470-10	25021-470	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101	N/A	ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	500 ug/5mL	1 VIAL in 1 CARTON (25021-470-10) / 5 mL in 1 VIAL
70511-112-10	70511-112	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium	LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181227	N/A	ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	200 ug/5mL	1 VIAL, SINGLE-USE in 1 CARTON (70511-112-10) / 5 mL in 1 VIAL, SINGLE-USE